mood stabilizer
A mood stabilizer is a drug used to even out the extreme swings of bipolar disorder, pulling a patient back from the highs of mania and the lows of depression toward a steadier baseline — and, crucially, helping prevent future episodes rather than just treating the current one.
The prototype is lithium, a simple metal ion that reduces both mania and the risk of suicide, though its exact molecular action is still not fully understood; it is thought to modulate intracellular signalling pathways including inositol and GSK-3. Several antiepileptic drugs also serve as mood stabilizers — valproate, carbamazepine, and lamotrigine — and some second-generation antipsychotics are used in this role too.
These drugs treat acute mania, help in bipolar depression, and are taken long-term as maintenance to prevent relapse. The choice depends on whether the patient's pattern tilts more toward mania or depression and on side-effect tolerability.
Lithium has a narrow therapeutic window: too little does nothing, too much causes tremor, confusion, and kidney or thyroid damage, so blood levels must be monitored regularly. Valproate carries a high risk of birth defects and must be avoided in pregnancy, and lamotrigine can cause a serious rash if titrated too quickly.
A patient with bipolar disorder on long-term lithium has blood levels and thyroid and kidney function checked periodically to keep the drug both effective and safe.
Routine monitoring is built into long-term mood-stabilizer care.
Lithium is a classic teaching case for therapeutic drug monitoring: its narrow therapeutic window means the difference between an effective and a toxic blood level is small, so levels are checked routinely.